Search

Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.

This is a very interesting and noteworthy study. We know that autologous transplants can cause severe anemia, but we also know that EPO therapy does not work well in the immediate post-transplant setting. This is probably because the bone marrow graft comes from the patient himself and is therefore usually pretreated with chemotherapy and less […]